IoMT ABOUT US & WHAT WE DO A complete solution for the IoMT - - PowerPoint PPT Presentation
IoMT ABOUT US & WHAT WE DO A complete solution for the IoMT with early application focus in research, clinical trials and precision medicine. The IO IOMT The Internet of Medical Things refers to the connected system of medical devices
CBDS HEALTH
ABOUT US & WHAT WE DO
A complete solution for the IoMT with early application focus in research, clinical trials and precision medicine.
The IO IOMT
The Internet of Medical Things refers to the connected system of medical devices and applications that collect data which is then provided to healthcare IT systems through online computer networks.
2
CBDS HEALTH
OUR OPPORTUNITY
The he Internet of
l Thin hings (IoMT) ) is transforming how we keep people healthy as the demand for solutions that lower healthcare costs rises. A report by Allied Market Research predicts that the IoMT market will reach $136.8 billion worldwide by 2021.
3
CBDS HEALTH
Management, Data Capture, Comms & Security
4
CBDS HEALTH
RESEARCH/CLINICAL TRIAL MANAGEMENT (CTMS)
5
The CBDS Health CMTS platform is a customizable software solution that modularly composes clinical trials with the benefit of avoiding disjointed
Development Environment” allows developers to collaborate worldwide using shared, standardized tools that provide process and data integrity, the CMTS platform brings these capabilities to the medical and scientific research
entire clinical trials at the click of a button.
CBDS HEALTH
REMOTE PATIENT DATA CAPTURE (IOMT)
6
CBDS Data Capture “Standard Sleep Lab” Configuration
CBDS HEALTH
ONLINE/MOBILE COMMUNICATIONS (MHEALTH)
7
The CBDS Health online/mobile communications platform enables multi-party screen sharing, file sharing, video and voice calling - including landline support, SMS, chat, and application data exchange. All of these interactions can be recorded for future review. These communications are powered by a leading global platform serving nearly 40 billion interactions a year while maintaining a 99.95% service level agreement and HIPAA compliance. SNS Research estimates that the mHealth market accounted for over $23 Billion in 2017 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of more than 35% over the next three years.
CBDS HEALTH
8
IDENTITY AND DATA/DEVICE SECURITY
Next generation health industry security requires decentralization by leveraging both software and hardware mechanisms for users and devices/machines on the IoMT. 2017 figures put healthcare at the top of the list when it comes to industries with the highest number of data breaches. According to the Information Commissioners Office (UK) the health sector alone accounts for 43% of all data breach related incidents. For Demonstration:
CBDS HEALTH
Research, Clinical Trials & Precision Medicine
9
CBDS HEALTH
Cannabis Research and Clinical Trials
10
CBDS HEALTH
11
CANNABIS RESEARCH & CLINICAL TRIALS
For an overview of GrowBuddy:
Grow Smarter
CBDS Health and GrowBuddy have executed an investment and development agreement to integrate their platforms for the provision of a complete solution for
product research and clinical trials in the Cannabinoid sector. The GrowBuddy
cultivation application currently has +44,000 users.
CBDS HEALTH
CANNABIS RESEARCH/TRIAL MANAGEMENT
12
Cannabis contains several hundred active ingredients in the form of cannabinoids, terpenes, and flavonoids. The benefit of these active ingredients is largely based on feedback from patients and their caregivers backed by preclinical and observational studies. The cannabis industry needs to adopt traditional product research and pharmaceutical practices in order to continue making product and scientific advancements.
CBDS HEALTH
CANNABIS PRODUCT RESEARCH
13
Cannabis research & clinical trials must track from seed and strain lineage through to finished product. Performing research & clinical trials for cannabis requires definitive tracking of not just the trial itself but also the cultivation and acquisition of the targeted cannabis
produce cannabis products the same way, every time to ensure the integrity of the research/trial.
CBDS HEALTH
CANNABIS RESEARCH - PATIENT DATA CAPTURE
14
CBDS Data Capture “Cannabis Sleep Lab” Configuration
CBDS HEALTH
Real World Evidence Clinical Trials & Precision Medicine
15
CBDS HEALTH
REAL WORLD EVIDENCE (RWE)
16
Real world evidence (RWE) is obtained from real world data (RWD), which are observational data obtained outside the medical facility/clinic. FD FDA: A: th the de development
RWE in n Cl Clin inical l Tria ials req requires more co comple lete, ac accurate an and va vali lidated da data.
medical, and pharmacy data from thousands of patients in real-time.
time of clinical trials.
improve its efficacy.
CBDS HEALTH
CBDS HEALTH RWE
17
The he CB CBDS Healt lth pl platfo form is s TES ESTED and nd we well ll-suit ited for
capturin ing pa patie ient da data for
therapeutic trea treatments in n chr chronic ic pa pain in; sl sleep di disorders; qu quali lity of
Parkinson’s disease; dementia; anxiety; depression; posttraumatic stress dis disorder; sc schizophrenia and nd ot
psychoses. The CBDS Health IoMT devices and HealthHub monitor patient behavior and activity away from the clinic, providing data regarding patient therapy compliance and actions that transpire after a patient leaves a medical facility. These devices provide objective reporting of actual activity, versus subjective patient reporting about how they feel.
CBDS HEALTH
PRECISION/PERSONALIZED MEDICINE
18
Precision/personalized medicine determines care guidelines based on the unique biological systems of a particular patient with IoMT opening the door for more personalized healthcare catered to each individual.
“The perfect clinical trial is one doctor and one patient”
virtual clinical trials platform at Oregon Health Science University
CBDS HEALTH
CBDS Health Inc. Versus The Industry
19
CBDS HEALTH
IOMT PLATFORM
20
The The CBD CBDS He Health IoMT platf latform has been 15 15 ye years in in th the makin
technology was developed under the OrcaTech initiative at the Oregon Health Science
more than one million hours of continuous patient monitoring data resulting in 130+ peer reviewed publications. CBDS has taken the Orcatech platform to the cloud and added its new core HealthHub and devices/services which expand the capabilities and bring intelligence to the edge of the
“An example of innovation the FDA would like to partner with.” Statement of Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, during
platform overview meeting .
CBDS HEALTH
ECONOMIC BENEFITS
21
Note te 1: 2014 costs and average savings - U.S. Department of Health and Human Services
Aver erage e Cl Clinical al Trial Co Cost sts R&D and and Pr Pre-Clinica cal Pha Phase se 1 Pha Phase se 2 Pha Phase se 3 FDA NDA/BLA LA Rev eview Pha Phase se Pha Phase se 4 Totals % Anti-Infective $ - $ 4,200,000 $ 14,200,000 $ 22,800,000 $ 2,000,000 $ 11,000,000 $ 54,200,000 Cardiovascular $ - $ 2,200,000 $ 7,000,000 $ 25,200,000 $ 2,000,000 $ 27,800,000 $ 64,200,000 Central Nervous System $ - $ 3,900,000 $ 13,900,000 $ 19,200,000 $ 2,000,000 $ 14,100,000 $ 53,100,000 Dermatology $ - $ 1,800,000 $ 8,900,000 $ 11,500,000 $ 2,000,000 $ 25,200,000 $ 49,400,000 Endocrine $ - $ 1,400,000 $ 12,100,000 $ 17,000,000 $ 2,000,000 $ 26,700,000 $ 59,200,000 Gastrointestinal $ - $ 2,400,000 $ 15,800,000 $ 14,500,000 $ 2,000,000 $ 21,800,000 $ 56,500,000 Genitourinary System $ - $ 3,100,000 $ 14,600,000 $ 17,500,000 $ 2,000,000 $ 6,800,000 $ 44,000,000 Hematology $ - $ 1,700,000 $ 19,600,000 $ 15,000,000 $ 2,000,000 $ 27,000,000 $ 65,300,000 Immunomodulation $ - $ 6,600,000 $ 16,000,000 $ 11,900,000 $ 2,000,000 $ 19,800,000 $ 56,300,000 Oncology $ - $ 4,500,000 $ 11,200,000 $ 22,100,000 $ 2,000,000 $ 38,900,000 $ 78,700,000 Ophthalmology $ - $ 5,300,000 $ 13,800,000 $ 30,700,000 $ 2,000,000 $ 17,600,000 $ 69,400,000 Pain and Anesthesia $ - $ 1,400,000 $ 17,000,000 $ 52,900,000 $ 2,000,000 $ 32,100,000 $ 105,400,000 Respiratory System $ - $ 5,200,000 $ 12,200,000 $ 23,100,000 $ 2,000,000 $ 72,900,000 $ 115,400,000 $ - $ 43,700,000 $ 176,300,000 $ 283,400,000 $ 26,000,000 $ 341,700,000 $ 871,100,000 Aver erage e Co Cost st1 $ $ - $ $ 3,361,538 $ $ 13,561,538 $ $ 21,800,000 $ $ 2,000,000 $ $ 26,284,615 $ $ 67, 7,007, 7,692 CB CBDS Heal ealth - Sav Savings Management Efficiency (min) $ 480,000 $ 480,000 $ 480,000 $ 480,000 $ 480,000 $ 480,000 $ $ 2,40 400,000 3.6% In-Home Testing $ - $ 537,846 $ 2,983,538 $ 3,706,000 $ - $ 4,468,385 $ $ 11,695,76 769 17. 7.5% Mobile Technologies $ - $ 268,923 $ 1,084,923 $ 2,616,000 $ - $ 3,154,154 $ $ 7, 7,124,000 10. 0.6% Aver erage e Sav Savings $ $ 480 480,000 $ $ 1,286,769 $ $ 4, 4,548,462 $ $ 6,802,000 $ $ 48 480,000 $ $ 8,102,538 $ $ 21,219,769 31.7%
CBDS Health Savings Versus Average Industry Cost
CBDS HEALTH
COMPARISON
CBDS Health Inc.
CBDS Health develops and markets software and hardware as a service (H/W&SaaS) for clinical trials and personalized medicine.
Medidata Solutions Inc.
Medidata Solutions develops and markets software as a service (SaaS) solutions for clinical trials.
Life of Trial Platform Cost Comparative (10 Years - 150 patients) $3,930,000 $7,100,000
22
Brian Leeners Founder & CEO
+1 604-862-4184 brian@cbdshealth.com www.cbdshealth.com